Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Robotic-assisted Hysterectomy: Single- vs. Multi-port Laparoscopic Access

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03373513
Recruitment Status : Not yet recruiting
First Posted : December 14, 2017
Last Update Posted : September 6, 2018
Sponsor:
Information provided by (Responsible Party):
Finn Friis Lauszus, Herning Hospital

Brief Summary:
robotic single site surgery (R-SSH) is a novel technique, which may be superior to conventional multiport hysterectomy in select patients regarding cosmesis and postoperative pain. We, perform a randomized trial to compare R-SSH with multiport laparoscopic hysterectomy with regard to the postoperative rehabilitation, cosmesis, the operational cost, and the perioperative morbidity.

Condition or disease Intervention/treatment Phase
Activity, Motor Pain Wound Procedure: Robotic single-site Hysterectomy Procedure: Laparoscopic hysterectomy Not Applicable

Detailed Description:

The study is scheduled to start February 2018 and compares robotic single-site hysterectomy to conventional multiport hysterectomy. Procedures are performed by an experienced two-surgeon team. Patients are randomized to either conventional multiport hysterectomy (N=62) or R-SSH (N=62). Eligibility criteria are the same as for study 1. Patient's satisfaction with body image and cosmesis is assessed at different time points pre- and postoperatively by means of validated cosmesis scales and Body Image Questionnaire. Postoperative pain and analgesia use will be registered as well as secondary outcome parameters as described above. A follow-up at 1, 3 and 6 month include evaluation of the scar and registration of port-site hernias and vaginal dehiscence or other complications. Interviews and diaries will include time of return to home and work, daily activities including sexuality The R-SSH is performed using da Vinci, Xi robotic system. One single port, diameter 2 cm is applied. Applying an additional assistant port is defined conversion of procedure The laparoscopy is performed using our standard equipment and 4 trocars, 5 mm each.

Socio-economical consequences of R-SSH versus conventional laparoscopic hysterectomy Study details in preparation

Sample size calculation was based a previous study on fast track hysterectomy, which showed a difference in return to work of 4 days. 62 women in each group is needed with standard deviation ±8 and a power of 80%. To include those not working, we calculated that with an expected visual analog pain score of 0.86 ±0.2 and 62 in each group the sample was sufficient to detect of difference of 0.1 in visual analog pain score with a power of 80%. All calculation are based on two-sided testing with alpha of 0.05.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 124 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Women are randomized to either robotic single site or multi port lapsoscopic hystrectomy
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Robotic-assisted Hysterectomy: Single- vs. Multi-port Laparoscopic Access
Estimated Study Start Date : February 1, 2019
Estimated Primary Completion Date : January 1, 2022
Estimated Study Completion Date : December 1, 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Hysterectomy

Arm Intervention/treatment
Active Comparator: Robotic single-site hysterectomy
Robotic single-site hysterectomy is performed in this arm
Procedure: Robotic single-site Hysterectomy
Robotic assisted Periumbilical single incision hysterectomy

Active Comparator: Multiport Laparoscopy
Multiport Laparoscopic hysterectomy is performed in this other arm
Procedure: Laparoscopic hysterectomy
Multiport laparoscopic hysterectomy




Primary Outcome Measures :
  1. Return-to-work [ Time Frame: up to six months after operation or until work is resumed, whichever came first ]
    Time from operation to return work


Secondary Outcome Measures :
  1. Pain measured by subjective score [ Time Frame: Visual analogue pain score first, second, third, fourth, fifth, and six months after operation ]
    Visual analogue pain score with a minimum of '0' up to '10' on a 10 cm continious scale



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   women undergoing hysterectomy
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • hysterectomy on benign indication,
  • American Society of Anesthetists group 1 or 2,
  • BMI less than 35 kg/m2
  • uterine size less than 300 g estimated by ultrasound, using Ferraris formula.

Exclusion Criteria:

  • adhesions
  • prior extensive abdominal surgery
  • prior midline incision,
  • cutis laxa of abdomen surgery
  • endometriosis
  • more than 1 cesarean section
  • malignant disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03373513


Contacts
Layout table for location contacts
Contact: Finn F Lauszus, MD,PhD 28495640 finlau@rm.dk

Locations
Layout table for location information
Denmark
Gynecology Dept. Herning Hospital
Herning, Denmark, 7400
Sponsors and Collaborators
Herning Hospital
Investigators
Layout table for investigator information
Principal Investigator: Finn F Lauszus, MD,PhD Gynecology Department, Herning Hospital
  Study Documents (Full-Text)

Documents provided by Finn Friis Lauszus, Herning Hospital:
Informed Consent Form  [PDF] December 12, 2017
Study Protocol  [PDF] December 12, 2017

Publications:
Layout table for additonal information
Responsible Party: Finn Friis Lauszus, Research Specialist, Senoir Consultant, Assistant Professor, Herning Hospital
ClinicalTrials.gov Identifier: NCT03373513    
Other Study ID Numbers: R-SSH
First Posted: December 14, 2017    Key Record Dates
Last Update Posted: September 6, 2018
Last Verified: September 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: via meeting, posters, abstracts, and publications

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Finn Friis Lauszus, Herning Hospital:
Return-to-work, Visual analogue pain score, Cosmesis